Jacqueline (Jackie) Gerhart earned her Bachelor’s and Master’s degrees in Biomedical Engineering at Drexel University in Philadelphia, PA. She worked in various roles across the drug development pipeline for over five years as a scientist at GlaxoSmithKline. Jackie is currently pursuing her PhD in Pharmaceutical Sciences at the Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill, where her research focuses on using modeling and simulation techniques to determine safe and effective drug doses in children with obesity.